PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, RW 5, Kenari, Kec. Senen, Kota Jakarta Pusat, Jakarta, 10430, Indonesia. gilbert.lazarus@ui.ac.id.\', \'Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, RW 5, Kenari, Kec. Senen, Kota Jakarta Pusat, Jakarta, 10430, Indonesia.\', \'Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00262-021-02990-9
?:hasPublicationType
?:journal
  • Cancer immunology, immunotherapy : CII
is ?:pmid of
?:pmid
?:pmid
  • 34173850
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all